IBDEI0AU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4563,1,3,0)
 ;;=3^SCREEN-GOUT
 ;;^UTILITY(U,$J,358.3,4563,1,4,0)
 ;;=4^Z13.89
 ;;^UTILITY(U,$J,358.3,4563,2)
 ;;=^5062720
 ;;^UTILITY(U,$J,358.3,4564,0)
 ;;=Z13.89^^34^297^28
 ;;^UTILITY(U,$J,358.3,4564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4564,1,3,0)
 ;;=3^SCREEN-GU COND NEC
 ;;^UTILITY(U,$J,358.3,4564,1,4,0)
 ;;=4^Z13.89
 ;;^UTILITY(U,$J,358.3,4564,2)
 ;;=^5062720
 ;;^UTILITY(U,$J,358.3,4565,0)
 ;;=Z11.6^^34^297^29
 ;;^UTILITY(U,$J,358.3,4565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4565,1,3,0)
 ;;=3^SCREEN-HELMINTHIASIS
 ;;^UTILITY(U,$J,358.3,4565,1,4,0)
 ;;=4^Z11.6
 ;;^UTILITY(U,$J,358.3,4565,2)
 ;;=^5062676
 ;;^UTILITY(U,$J,358.3,4566,0)
 ;;=Z13.0^^34^297^30
 ;;^UTILITY(U,$J,358.3,4566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4566,1,3,0)
 ;;=3^SCREEN-HEMOGLOBINOPATH NEC
 ;;^UTILITY(U,$J,358.3,4566,1,4,0)
 ;;=4^Z13.0
 ;;^UTILITY(U,$J,358.3,4566,2)
 ;;=^5062699
 ;;^UTILITY(U,$J,358.3,4567,0)
 ;;=Z11.51^^34^297^31
 ;;^UTILITY(U,$J,358.3,4567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4567,1,3,0)
 ;;=3^SCREEN-HPV
 ;;^UTILITY(U,$J,358.3,4567,1,4,0)
 ;;=4^Z11.51
 ;;^UTILITY(U,$J,358.3,4567,2)
 ;;=^5062674
 ;;^UTILITY(U,$J,358.3,4568,0)
 ;;=Z13.6^^34^297^32
 ;;^UTILITY(U,$J,358.3,4568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4568,1,3,0)
 ;;=3^SCREEN-HYPERTENSION
 ;;^UTILITY(U,$J,358.3,4568,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,4568,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,4569,0)
 ;;=Z13.228^^34^297^33
 ;;^UTILITY(U,$J,358.3,4569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4569,1,3,0)
 ;;=3^SCREEN-INBORN ERR METAB
 ;;^UTILITY(U,$J,358.3,4569,1,4,0)
 ;;=4^Z13.228
 ;;^UTILITY(U,$J,358.3,4569,2)
 ;;=^5062703
 ;;^UTILITY(U,$J,358.3,4570,0)
 ;;=Z13.0^^34^297^36
 ;;^UTILITY(U,$J,358.3,4570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4570,1,3,0)
 ;;=3^SCREEN-IRON DEFIC ANEMIA
 ;;^UTILITY(U,$J,358.3,4570,1,4,0)
 ;;=4^Z13.0
 ;;^UTILITY(U,$J,358.3,4570,2)
 ;;=^5062699
 ;;^UTILITY(U,$J,358.3,4571,0)
 ;;=Z13.6^^34^297^37
 ;;^UTILITY(U,$J,358.3,4571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4571,1,3,0)
 ;;=3^SCREEN-ISCHEMIC HEART DIS
 ;;^UTILITY(U,$J,358.3,4571,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,4571,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,4572,0)
 ;;=Z11.6^^34^297^38
 ;;^UTILITY(U,$J,358.3,4572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4572,1,3,0)
 ;;=3^SCREEN-LEISHMANIASIS
 ;;^UTILITY(U,$J,358.3,4572,1,4,0)
 ;;=4^Z11.6
 ;;^UTILITY(U,$J,358.3,4572,2)
 ;;=^5062676
 ;;^UTILITY(U,$J,358.3,4573,0)
 ;;=Z11.2^^34^297^39
 ;;^UTILITY(U,$J,358.3,4573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4573,1,3,0)
 ;;=3^SCREEN-LEPROSY
 ;;^UTILITY(U,$J,358.3,4573,1,4,0)
 ;;=4^Z11.2
 ;;^UTILITY(U,$J,358.3,4573,2)
 ;;=^5062671
 ;;^UTILITY(U,$J,358.3,4574,0)
 ;;=Z13.220^^34^297^40
 ;;^UTILITY(U,$J,358.3,4574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4574,1,3,0)
 ;;=3^SCREEN-LIPOID DISORDERS
 ;;^UTILITY(U,$J,358.3,4574,1,4,0)
 ;;=4^Z13.220
 ;;^UTILITY(U,$J,358.3,4574,2)
 ;;=^5062702
 ;;^UTILITY(U,$J,358.3,4575,0)
 ;;=Z11.6^^34^297^41
 ;;^UTILITY(U,$J,358.3,4575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4575,1,3,0)
 ;;=3^SCREEN-MALARIA
 ;;^UTILITY(U,$J,358.3,4575,1,4,0)
 ;;=4^Z11.6
 ;;^UTILITY(U,$J,358.3,4575,2)
 ;;=^5062676
 ;;^UTILITY(U,$J,358.3,4576,0)
 ;;=Z13.21^^34^297^42
 ;;^UTILITY(U,$J,358.3,4576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4576,1,3,0)
 ;;=3^SCREEN-MALNUTRITION
 ;;^UTILITY(U,$J,358.3,4576,1,4,0)
 ;;=4^Z13.21
 ;;^UTILITY(U,$J,358.3,4576,2)
 ;;=^5062701
 ;;^UTILITY(U,$J,358.3,4577,0)
 ;;=Z13.89^^34^297^44
